These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 15702147

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B, Speizer FE.
    N Engl J Med; 1995 Jun 15; 332(24):1589-93. PubMed ID: 7753136
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Unopposed estrogen therapy and the risk of invasive breast cancer.
    Chen WY, Manson JE, Hankinson SE, Rosner B, Holmes MD, Willett WC, Colditz GA.
    Arch Intern Med; 2006 May 08; 166(9):1027-32. PubMed ID: 16682578
    [Abstract] [Full Text] [Related]

  • 6. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec 08; 15(6):453-65. PubMed ID: 11826770
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Last word on hormone replacement and breast cancer?].
    Rookus MA, van Leeuwen FE, Hamerlynck JV.
    Ned Tijdschr Geneeskd; 1998 Jan 17; 142(3):111-3. PubMed ID: 9557006
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study.
    Bakken K, Alsaker E, Eggen AE, Lund E.
    Int J Cancer; 2004 Oct 20; 112(1):130-4. PubMed ID: 15305384
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of HRT and the subsequent risk of cancer.
    Beral V, Banks E, Reeves G, Appleby P.
    J Epidemiol Biostat; 1999 Oct 20; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
    [Abstract] [Full Text] [Related]

  • 15. Postmenopausal hormone therapy and breast cancer.
    Prescrire Int; 2009 Apr 20; 18(100):66-7. PubMed ID: 19585723
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue.
    Gadducci A, Biglia N, Cosio S, Sismondi P, Genazzani AR.
    Gynecol Endocrinol; 2009 Dec 20; 25(12):807-15. PubMed ID: 19906000
    [Abstract] [Full Text] [Related]

  • 18. Hormone replacement therapy in relation to risk of cataract extraction: a prospective study of women.
    Lindblad BE, Håkansson N, Philipson B, Wolk A.
    Ophthalmology; 2010 Mar 20; 117(3):424-30. PubMed ID: 20045566
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cancer issues.
    Marsden J, Sturdee D.
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb 20; 23(1):87-107. PubMed ID: 19036643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.